Wang Xue, Zeng Li, Feng Xue, Zhao Na, Feng Na, Du Xin
Medical Center of Hematology, The Second Affiliated Hospital, Army Medical University, Chongqing, China.
Front Oral Health. 2023 Jan 30;3:977830. doi: 10.3389/froh.2022.977830. eCollection 2022.
Oral mucositis (OM) is one of the most common adverse effects of radiotherapy and chemotherapy. It greatly affects the patients' quality of life and hinders cancer treatment implementation. Treating OM with mouthwash is a widely used strategy that can effectively relieve symptoms and promote healing. However, the wide mouthwash selection confuses clinicians. This Bayesian network meta-analysis aimed to compare the effects of various mouthwash types used to treat OM and provide high-level evidence-based recommendations for OM treatment.
Database search included PubMed, Embase, Cochrane Library, and Web of Science from inception to April 21, 2022. The primary outcome was OM score improvement following the World Health Organization grades. The randomized controlled trial (RCT) bias risk assessment tool provided in the Cochrane Handbook assessed the studies' risk of bias. We performed pairwise and Bayesian network meta-analysis with random effects following the PRISMA guideline.
The study included 13 RCTs with 570 patients. Pairwise comparisons showed that povidone-iodine was more effective than chlorhexidine (weighted mean difference [WMD], -2.64; 95% confidence interval [CI], -2.72 to -2.56) but inferior to granulocyte-macrophage colony-stimulating factor (GM-CSF; WMD, 0.20; 95% CI, 0.06-0.34) after one week of mouthwash treatment. Vitamin E (WMD, -0.94; 95% CI, -1.03 to -0.85), natural drugs (WMD, -0.93; 95% CI, -1.46 to -0.40), and phenytoin (WMD, -0.38; 95% CI, -0.59 to -0.17) exhibited better therapeutic effects than a placebo after three weeks of treatment. Bayesian network meta-analysis showed that povidone-iodine was superior to chlorhexidine in treating OM (WMD, 2.63; 95% CI, 0.20-5.01). Other mouthwashes showed no significant differences. Rank probability indicated that the best OM therapeutic mouthwashes were GM-CSF (54%), vitamin E (24%), and natural drugs (43%) after one, two, and three weeks of treatment, respectively.
GM-CSF was the most effective mouthwash type for OM treatment. When considering the cost and effectiveness, povidone-iodine and sodium bicarbonate might be the most advantageous. Furthermore, natural drugs have the same potential in treating OM. Safety and acceptability are their most outstanding characteristic.
口腔黏膜炎(OM)是放疗和化疗最常见的不良反应之一。它极大地影响患者的生活质量,并阻碍癌症治疗的实施。使用漱口水治疗OM是一种广泛应用的策略,可有效缓解症状并促进愈合。然而,漱口水种类繁多,这让临床医生感到困惑。这项贝叶斯网络荟萃分析旨在比较用于治疗OM的各种漱口水的效果,并为OM治疗提供高级别的循证建议。
数据库检索包括从建库至2022年4月21日的PubMed、Embase、Cochrane图书馆和Web of Science。主要结局是按照世界卫生组织分级标准OM评分的改善情况。使用Cochrane手册中提供的随机对照试验(RCT)偏倚风险评估工具评估研究的偏倚风险。我们按照PRISMA指南进行了随机效应的成对和贝叶斯网络荟萃分析。
该研究纳入了13项RCT,共570例患者。成对比较显示,漱口水治疗一周后,聚维酮碘比氯己定更有效(加权均数差[WMD],-2.64;95%置信区间[CI],-2.72至-2.56),但不如粒细胞-巨噬细胞集落刺激因子(GM-CSF;WMD,0.20;95%CI,0.06 - 0.34)。治疗三周后,维生素E(WMD,-0.94;95%CI,-1.03至-0.85)、天然药物(WMD,-0.93;95%CI,-1.46至-0.40)和苯妥英(WMD,-0.38;95%CI,-0.59至-0.17)比安慰剂表现出更好的治疗效果。贝叶斯网络荟萃分析显示,聚维酮碘在治疗OM方面优于氯己定(WMD,2.63;95%CI,0.20 - 5.01)。其他漱口水未显示出显著差异。排序概率表明,治疗一、二、三周后,治疗OM效果最佳的漱口水分别是GM-CSF(54%)、维生素E(24%)和天然药物(43%)。
GM-CSF是治疗OM最有效的漱口水类型。考虑到成本和效果,聚维酮碘和碳酸氢钠可能是最具优势的。此外,天然药物在治疗OM方面具有同样的潜力。安全性和可接受性是它们最突出的特点。